140 related articles for article (PubMed ID: 23916815)
1. The V1/V2 loop of HIV-1 gp120 is necessary for Tat binding and consequent modulation of virus entry.
Cardaci S; Soster M; Bussolino F; Marchiò S
FEBS Lett; 2013 Sep; 587(18):2943-51. PubMed ID: 23916815
[TBL] [Abstract][Full Text] [Related]
2. Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunodeficiency virus type 1 Tat and gp120 proteins.
Bugatti A; Urbinati C; Ravelli C; De Clercq E; Liekens S; Rusnati M
Antimicrob Agents Chemother; 2007 Jul; 51(7):2337-45. PubMed ID: 17452490
[TBL] [Abstract][Full Text] [Related]
3. Glycan deletions in the HIV-1 gp120 V1/V2 domain compromise viral infectivity, sensitize the mutant virus strains to carbohydrate-binding agents and represent a specific target for therapeutic intervention.
Auwerx J; François KO; Covens K; Van Laethem K; Balzarini J
Virology; 2008 Dec; 382(1):10-9. PubMed ID: 18930512
[TBL] [Abstract][Full Text] [Related]
4. Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor.
Labrosse B; Treboute C; Brelot A; Alizon M
J Virol; 2001 Jun; 75(12):5457-64. PubMed ID: 11356952
[TBL] [Abstract][Full Text] [Related]
5. Cell surface-associated Tat modulates HIV-1 infection and spreading through a specific interaction with gp120 viral envelope protein.
Marchiò S; Alfano M; Primo L; Gramaglia D; Butini L; Gennero L; De Vivo E; Arap W; Giacca M; Pasqualini R; Bussolino F
Blood; 2005 Apr; 105(7):2802-11. PubMed ID: 15591114
[TBL] [Abstract][Full Text] [Related]
6. A broad spectrum anti-HIV inhibitor significantly disturbs V1/V2 domain rearrangements of HIV-1 gp120 and inhibits virus entry.
Berinyuy E; Soliman ME
J Recept Signal Transduct Res; 2016; 36(2):119-29. PubMed ID: 26446906
[TBL] [Abstract][Full Text] [Related]
7. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.
Maerz AL; Drummer HE; Wilson KA; Poumbourios P
J Virol; 2001 Jul; 75(14):6635-44. PubMed ID: 11413331
[TBL] [Abstract][Full Text] [Related]
8. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I
Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516
[TBL] [Abstract][Full Text] [Related]
9. Is the V3 loop involved in HIV binding to CD4?
Dettin M; Ferranti P; Scarinci C; Picariello G; Di Bello C
Biochemistry; 2003 Aug; 42(30):9007-12. PubMed ID: 12885233
[TBL] [Abstract][Full Text] [Related]
10. Identification of the DC-SIGN-interactive domains on the envelope glycoprotein of HIV-1 CRF07_BC.
Liao CF; Wang SF; Lin YT; Ho DD; Chen YM
AIDS Res Hum Retroviruses; 2011 Aug; 27(8):831-9. PubMed ID: 21142800
[TBL] [Abstract][Full Text] [Related]
11. Minimal sequence requirements for synthetic peptides derived from the V3 loop of the human immunodeficiency virus type 1 (HIV-1) to enhance HIV-1 binding to cells and infection.
Zanotto C; Calderazzo F; Dettin M; Di Bello C; Autiero M; Guardiola J; Chieco-Bianchi L; De Rossi A
Virology; 1995 Feb; 206(2):807-16. PubMed ID: 7856094
[TBL] [Abstract][Full Text] [Related]
12. Normal T cell receptor-mediated signaling in T cell lines stably expressing HIV-1 envelope glycoproteins.
Tani Y; Tian H; Lane HC; Cohen DI
J Immunol; 1993 Dec; 151(12):7337-48. PubMed ID: 7903106
[TBL] [Abstract][Full Text] [Related]
13. Binding of HIV-1 gp120 glycoprotein to silica nanoparticles modified with CD4 glycoprotein and CD4 peptide fragments.
Cheng K; El-Boubbou K; Landry CC
ACS Appl Mater Interfaces; 2012 Jan; 4(1):235-43. PubMed ID: 22117536
[TBL] [Abstract][Full Text] [Related]
14. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.
Trkola A; Dragic T; Arthos J; Binley JM; Olson WC; Allaway GP; Cheng-Mayer C; Robinson J; Maddon PJ; Moore JP
Nature; 1996 Nov; 384(6605):184-7. PubMed ID: 8906796
[TBL] [Abstract][Full Text] [Related]
15. Gold manno-glyconanoparticles for intervening in HIV gp120 carbohydrate-mediated processes.
Di Gianvincenzo P; Chiodo F; Marradi M; Penadés S
Methods Enzymol; 2012; 509():21-40. PubMed ID: 22568899
[TBL] [Abstract][Full Text] [Related]
16. Interaction of human immunodeficiency virus gp120 with the voltage-gated potassium channel BEC1.
Herrmann M; Ruprecht K; Sauter M; Martinez J; van Heteren P; Glas M; Best B; Meyerhans A; Roemer K; Mueller-Lantzsch N
FEBS Lett; 2010 Aug; 584(16):3513-8. PubMed ID: 20638388
[TBL] [Abstract][Full Text] [Related]
17. HbAHP-25, an In-Silico Designed Peptide, Inhibits HIV-1 Entry by Blocking gp120 Binding to CD4 Receptor.
Bashir T; Patgaonkar M; Kumar SC; Pasi A; Reddy KV
PLoS One; 2015; 10(4):e0124839. PubMed ID: 25915507
[TBL] [Abstract][Full Text] [Related]
18. Expression and characterization of a single-chain polypeptide analogue of the human immunodeficiency virus type 1 gp120-CD4 receptor complex.
Fouts TR; Tuskan R; Godfrey K; Reitz M; Hone D; Lewis GK; DeVico AL
J Virol; 2000 Dec; 74(24):11427-36. PubMed ID: 11090138
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for the interaction between focal adhesion kinase and CD4.
Garron ML; Arthos J; Guichou JF; McNally J; Cicala C; Arold ST
J Mol Biol; 2008 Feb; 375(5):1320-8. PubMed ID: 18078954
[TBL] [Abstract][Full Text] [Related]
20. The HIV-1 envelope glycoprotein gp120 features four heparan sulfate binding domains, including the co-receptor binding site.
Crublet E; Andrieu JP; Vivès RR; Lortat-Jacob H
J Biol Chem; 2008 May; 283(22):15193-200. PubMed ID: 18378683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
